Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
9 hedge funds and large institutions have $5.85M invested in Forward Pharma A/S American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
80% more funds holding
Funds holding: 5 → 9 (+4)
13% less capital invested
Capital invested by funds: $6.72M → $5.85M (-$870K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$771K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$302K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$178K |
| 4 |
Goldman Sachs
New York
|
+$136K |
| 5 |
Morgan Stanley
New York
|
+$108K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$840K |
| 2 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
-$121K |
FWP Hedge Fund Activity: Q3 2021 in Review
9 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q3 2021, worth a combined $5.85M — down 13% from $6.72M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new FWP positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $771K. The largest seller was BVF Inc, cutting an estimated $840K.
- 9 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q3 2021, up from 5 in Q2 2021.
- Funds reported $5.85M of Forward Pharma A/S American Depositary Shares stock for Q3 2021, down 13% quarter-over-quarter.
- 5 funds opened new Forward Pharma A/S American Depositary Shares positions in Q3 2021 and 1 closed out, a net change of +4 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q3 2021 was Renaissance Technologies, an estimated $771K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q3 2021 was BVF Inc, an estimated $840K sold.
Based on aggregated 13F filings for Q3 2021.